NANO in New York4 Nov 2023 18:54
Nano management are in NYC on what city types like to call a 'non-deal roadshow' - essentially a series of presentations to institutional investors both new and existing for the purpose of simply highlighting the investment proposition (ie., why the shares are cheap and the instos should consider building or adding to their positions, rather than as a precursor to raising money, which NANO obviously has no need to do) - and not in any way to discuss or plan for a NASDAQ listing. The reason shareholders should be more than mildly excited about this news is: 1. small cap UK companies - no matter how desperately cheap they may be - don't do these formal roadshows hardly at all anymore in this grinding small cap bear market, mainly because almost every single UK company that may want to do such a tour of US instos would necessarily be deemed to be doing it precisely as a precursor to raising money, and US hedge funds and long-onlys DO NOT want to see such companies right now and therefore often reject out-of-hand any such meeting requests with prejudice. Said a different way, the fact that NANO seems to have a decent schedule of funds to see that includes many who are looking at the investment case for the first time, is at least a partial endorsement of the unique risk-reward case of building a position at these prices ('...Listen mate, it may not be the most liquid name but you get an interesting, growing IP exploitation business + the real prospect(s) of significant commercial production for less than nothing + around 5-7p of pro-forma net cash, AND in a couple of months you get 62.5%-75% (and very possibly more if activists get involved) of your investment back in some form of capital return, so risk/reward is ridiculously skewed in your favour and liquidity is waaaaay less important than it normally might be.....'); 2. Also, doing a non-deal roadshow now in the US so close to year-end and the near-promised breakthrough commercial deal, demonstrates a level of confidence by management in the story they're telling in the first place. Of course the proof of this pudding is whether the hugely favourable valuation-risk/reward balance and the fundamental story are enough to entice new buyers in over the next couple weeks. FINALLY: some shareholders here need to forget about hoping for a NASDAQ listing as some sort of magic re-rating system for foreign tech companies like NANO. First off, the entire process is an arduous, expensive pain in butt, that has long since stopped being worth the effort and cost. Small cap NASDAQ has not suffered as badly as small cap AIM to be sure, but it has been a particularly miserable 18 months over there as well and the market is riddled with cheap-looking biotechs, SPACs, etc, all down 80%+ from their highs (despite the massive short squeeze in a lot of names just this past week!), so a total of no one over there is waiting for a Nanoco listing anytime soon. The mystique of a NASDAQ listing is well and truly over